Bone marrow cells from 5-week-old mice were plated into 12-well plates at 2.5×106 cells per well for CFU-ALP assays and at 5×106 cells per well for CFU-O assays, and were cultured in α-MEM containing 10% FBS, 50 µg/ml ascorbic acid, and 10 nM β-glycerophosphate.
Evaluation of the modified surfaces via XPS and toluidine blue O assay confirmed the presence of the peptide on the surface and electrochemical analysis demonstrated unaltered properties of the peptide-modified films.
After culturing in adipogenic medium for 21 days, differentiated adipocytes were detected by an Oil Red O assay.
HIV testing was undertaken using HIV ELISA testing performed on DBS samples for detecting antibodies to HIV using the Vironostika Uni-Form 11 plus O Assay, Biomerieux, with results being recorded as negative or positive.
Strikingly, de- O-GlcNAcylation assays with the TAB1, FoxO1 and CREB glycoprotein substrates identified mutants of residues some distance from the active site (I176L, S190A, S190Q, T217A, E218S, F223S and K289A) with reduced activity against one or more of the protein substrates, yet unimpaired 4MU-GlcNAc hydrolysis.
The only artificially synthesized compound belonging to type O was assayed for physiological activity and was found to inhibit the 5-LO X[41].
The export of Tat-AldO was assayed by cell fractionation and immunoblotting.
Cultures were stained with 1% alizarin red S (Wako) at day 20 for the CFU-O assay of Cthrc1-null mice, and at day 16 for that of Cthrc1 transgenic mice, respectively.
The Oil Red-O assay was performed, but did not show any significant difference between the strains.
In addition, low-level SHIV-specific antibodies may have been below the limit of detection of the Bio-Rad 1/2 plus O EIA assay, although this assay is considered more sensitive than commercial Western Blotting techniques for the diagnosis of sero-conversion.
